BMO Capital raised the firm’s price target on Corebridge (CRBG) to $44 from $43 and keeps an Outperform rating on the shares. The company’s variable annuity risk transfer bolsters its free cash flow stability, which the firm had already viewed as underappreciated, the analyst tells investors in a research note.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRBG:
- Corebridge Financial’s Strategic Moves and Reinsurance Agreement Justify Buy Rating
- Corebridge price target raised to $40 from $37 at Morgan Stanley
- Corebridge price target raised to $45 from $38 at Barclays
- Corebridge enters $2.8B reinsurance agreement with CS Life Re
- Corebridge Financial Announces Major Reinsurance Transaction